BlackRock’s Quince Therapeutics QNCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$554K Sell
335,738
-9,710
-3% -$16K ﹤0.01% 4344
2025
Q1
$459K Sell
345,448
-102,285
-23% -$136K ﹤0.01% 4376
2024
Q4
$837K Buy
447,733
+89,375
+25% +$167K ﹤0.01% 4211
2024
Q3
$278K Buy
358,358
+3,570
+1% +$2.77K ﹤0.01% 4409
2024
Q2
$266K Buy
354,788
+22,702
+7% +$17K ﹤0.01% 4439
2024
Q1
$352K Sell
332,086
-3,518
-1% -$3.73K ﹤0.01% 4407
2023
Q4
$352K Sell
335,604
-838
-0.2% -$880 ﹤0.01% 4436
2023
Q3
$377K Sell
336,442
-3,273
-1% -$3.67K ﹤0.01% 4433
2023
Q2
$511K Buy
339,715
+15,809
+5% +$23.8K ﹤0.01% 4392
2023
Q1
$505K Sell
323,906
-26,248
-7% -$40.9K ﹤0.01% 4442
2022
Q4
$223K Sell
350,154
-179,593
-34% -$114K ﹤0.01% 4739
2022
Q3
$705K Buy
529,747
+29,961
+6% +$39.9K ﹤0.01% 4527
2022
Q2
$1.11M Sell
499,786
-904,251
-64% -$2M ﹤0.01% 4410
2022
Q1
$8.69M Buy
1,404,037
+7,067
+0.5% +$43.7K ﹤0.01% 3574
2021
Q4
$17.6M Buy
1,396,970
+71,922
+5% +$908K ﹤0.01% 3292
2021
Q3
$121M Buy
1,325,048
+40,476
+3% +$3.71M ﹤0.01% 2070
2021
Q2
$68.1M Sell
1,284,572
-77,965
-6% -$4.13M ﹤0.01% 2461
2021
Q1
$49.1M Buy
1,362,537
+398
+0% +$14.3K ﹤0.01% 2584
2020
Q4
$37.8M Buy
1,362,139
+400,761
+42% +$11.1M ﹤0.01% 2595
2020
Q3
$48.1M Buy
961,378
+55,966
+6% +$2.8M ﹤0.01% 2282
2020
Q2
$41.9M Buy
905,412
+252,691
+39% +$11.7M ﹤0.01% 2335
2020
Q1
$29.8M Buy
652,721
+67,102
+11% +$3.06M ﹤0.01% 2359
2019
Q4
$32.9M Buy
585,619
+430,294
+277% +$24.2M ﹤0.01% 2579
2019
Q3
$3.87M Buy
155,325
+15,930
+11% +$397K ﹤0.01% 3510
2019
Q2
$5.93M Buy
+139,395
New +$5.93M ﹤0.01% 3441